Unichem Laboratories Limited (BOM:506690)
India · Delayed Price · Currency is INR 384.60
-2.35 (-0.61%)
At close: Feb 12, 2026
Unichem Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 22,139 | 21,110 | 17,851 | 13,430 | 12,698 | 12,351 | |
Revenue Growth (YoY) | 16.33% | 18.25% | 32.92% | 5.76% | 2.81% | 11.91% |
Cost of Revenue | 10,754 | 9,219 | 7,949 | 6,064 | 4,686 | 4,260 |
Gross Profit | 11,386 | 11,891 | 9,903 | 7,366 | 8,013 | 8,091 |
Selling, General & Admin | 4,219 | 4,208 | 4,263 | 3,690 | 3,468 | 3,113 |
Other Operating Expenses | 4,995 | 5,034 | 4,771 | 4,098 | 3,742 | 4,062 |
Operating Expenses | 10,456 | 10,488 | 10,265 | 8,922 | 8,122 | 8,018 |
Operating Income | 929.5 | 1,403 | -362.8 | -1,556 | -109.01 | 72.76 |
Interest Expense | -273.3 | -207 | -221.5 | -162.52 | -50.21 | -44 |
Interest & Investment Income | 28.5 | 28.5 | 6.7 | 5.22 | 164.91 | 229.43 |
Earnings From Equity Investments | - | - | - | - | -10.61 | -3.43 |
Currency Exchange Gain (Loss) | 215.6 | 215.6 | 224 | 273.16 | 273.82 | 105.39 |
Other Non Operating Income (Expenses) | 138.9 | 3.7 | -0.9 | -41.33 | -29.37 | 43.45 |
EBT Excluding Unusual Items | 1,039 | 1,444 | -354.5 | -1,481 | 239.53 | 403.6 |
Gain (Loss) on Sale of Investments | 92.6 | 92.6 | 64.7 | 90.49 | -17.49 | 116.42 |
Gain (Loss) on Sale of Assets | 9.5 | 9.5 | 16.3 | 12.83 | -2.34 | -5.23 |
Other Unusual Items | 2,173 | - | -576.1 | -385.66 | - | - |
Pretax Income | 3,314 | 1,546 | -849.6 | -1,764 | 219.69 | 514.79 |
Income Tax Expense | 364.9 | 170.7 | 88 | 258.65 | -110.93 | 171.55 |
Earnings From Continuing Operations | 2,949 | 1,375 | -937.6 | -2,022 | 330.62 | 343.25 |
Net Income | 2,949 | 1,375 | -937.6 | -2,022 | 330.62 | 343.25 |
Net Income to Common | 2,949 | 1,375 | -937.6 | -2,022 | 330.62 | 343.25 |
Net Income Growth | - | - | - | - | -3.68% | - |
Shares Outstanding (Basic) | 70 | 70 | 70 | 70 | 70 | 70 |
Shares Outstanding (Diluted) | 71 | 71 | 70 | 70 | 71 | 70 |
Shares Change (YoY) | 0.28% | 0.31% | - | -0.25% | 0.25% | 0.01% |
EPS (Basic) | 41.88 | 19.53 | -13.32 | -28.72 | 4.70 | 4.88 |
EPS (Diluted) | 41.79 | 19.47 | -13.32 | -28.72 | 4.68 | 4.88 |
EPS Growth | - | - | - | - | -4.01% | - |
Free Cash Flow | - | -1,444 | -85.5 | -1,294 | -3,866 | -2,548 |
Free Cash Flow Per Share | - | -20.44 | -1.21 | -18.38 | -54.78 | -36.20 |
Dividend Per Share | - | - | - | - | 4.000 | 4.000 |
Gross Margin | 51.43% | 56.33% | 55.47% | 54.85% | 63.10% | 65.51% |
Operating Margin | 4.20% | 6.65% | -2.03% | -11.58% | -0.86% | 0.59% |
Profit Margin | 13.32% | 6.51% | -5.25% | -15.06% | 2.60% | 2.78% |
Free Cash Flow Margin | - | -6.84% | -0.48% | -9.63% | -30.45% | -20.63% |
EBITDA | 2,103 | 2,577 | 810.7 | -480.19 | 747.05 | 838.59 |
EBITDA Margin | 9.50% | 12.21% | 4.54% | -3.57% | 5.88% | 6.79% |
D&A For EBITDA | 1,174 | 1,174 | 1,174 | 1,076 | 856.06 | 765.83 |
EBIT | 929.5 | 1,403 | -362.8 | -1,556 | -109.01 | 72.76 |
EBIT Margin | 4.20% | 6.65% | -2.03% | -11.58% | -0.86% | 0.59% |
Effective Tax Rate | 11.01% | 11.04% | - | - | - | 33.32% |
Revenue as Reported | 22,628 | 21,463 | 18,167 | 13,815 | 13,173 | 12,853 |
Advertising Expenses | - | 168.2 | 215.2 | 117.46 | 144.12 | 26.81 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.